Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.370
+0.060 (1.39%)
At close: Aug 13, 2025, 4:00 PM
4.360
-0.010 (-0.23%)
After-hours: Aug 13, 2025, 4:06 PM EDT
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 368 employees as of December 31, 2024. The number of employees increased by 165 or 81.28% compared to the previous year.
Employees
368
Change (1Y)
165
Growth (1Y)
81.28%
Revenue / Employee
$552,899
Profits / Employee
-$181,894
Market Cap
258.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VNDA News
- 13 days ago - Vanda Pharmaceuticals Inc. (VNDA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results - PRNewsWire
- 21 days ago - Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025 - PRNewsWire
- 2 months ago - Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S - PRNewsWire
- 2 months ago - Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting - PRNewsWire
- 3 months ago - Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025 - PRNewsWire
- 3 months ago - Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results - PRNewsWire